麻豆传媒

Geriatrics >

Arthritis

News, opinions and meeting coverage in geriatrics.

One Gout Medication Comes Out on Top for CV Risk

Allopurinol the loser in retrospective comparison of two drugs

Cancer Risk Stable in Kids on Anti-TNFs

But background risks higher than in the general population

Selective IL-23 Inhibitor Shines in Mid-Stage PsA Trial

Risankizumab broadly effective against joint and skin symptoms

ACR Poster Roundup: Novel OA Tx; Cancer and RA Biologics

Selections from late-breaker poster presentations at rheumatology meeting

Biologics During Pregnancy Don't Raise Infection Risk for Infants

Gestational timing of exposure to biologic not an issue

Lipid Changes with Sirukumab Called 'Anti-Atherogenic'

Looking for silver-lining in cloudy trial data

Bruton's Tyrosine Kinase Marches on as Rheumatology Target

Industry remains interested despite lackluster phase II results with Celgene drug

Injecting Arthritic Knees Carries Sepsis Risk

Study identified four risk factors for sepsis after injections for knee pain.

In RA Patients, 2-Week Methotrexate Holiday Boosts Flu Vax Efficacy

Pragmatic trial shows 15%-20% bump in antibody titers

ACR 2017: Biosimilar Debate, Inflammation in OA, and More

Special lecture will look back at TNF as rheumatology drug target

Helping Kids with Chronic Diseases Move to Adult Care

Program at Wisconsin hospital develops self-management skills

Remission Common in Early SpA With Golimumab

Drug-free remission maintained for more than half after at least 12 months

RA Drug Active in Psoriatic Arthritis

Multiple endpoints improved with tofacitinib

A Rocky Start for Biosimilar Inflectra?

Infliximab biosimilar approved, but obstacles remain

Knee OA No Excuse to Skip Out on Physical Activity

Patients met thresholds for sit-to-stand, gait speed, and walking speed

Pro Soccer Career: A Risk Factor for Osteoarthritis in Men

Study also suggests controversial joint injections hike OA risk

Two RA Agents Similar in Head-to-Head Trial

Sponsor's hopes of proving Cimzia's superiority to Humira dashed

AHA: Study Finds Celebrex Safe for Heart

But naproxen not as heart safe as believed

Pearls From: Rheumatologist Philip Mease

An expert discusses new treatments for PsA and SpA

Tendon Inflammation May Signal Early RA

ACPA positive plus tenosynovitis flag preclinical RA

Outpatient Surgery Safe for Total Hip

No medical or surgical events put patients at risk

Leflunomide Tied to Modest Weight Loss in RA Patients

Weight loss at 6 months linked with higher 3-year mortality

RA Flares Common After Stopping Adalimumab

But anti-TNF discontinuation may be possible in select patients

Steroid Injections May Ease Jaw Pain in JIA

But relief is seldom complete and some patients get no benefit

Stroke Spike Seen in Autoimmune Disorders After Shingles Attacks

Risk increased by 50% in the first month

Squeeze Test in Finger/Toe Joints Won't Diagnose Arthritis

Sensitivity was low for metacarpophalangeal and metatarsophalangeal joints.

Stopping Enbrel Risky in Established RA

Fewer patients with longstanding disease flared if they remained on even a half dose of etanercept, and time to flare was greater.

Ultrasound After Steroid Shots Helps Slightly in Managing Knee OA

Changes visualized after intra-articular injections are small and of borderline utility.

Stop DMARDs Before Orthopedic Surgery in RA Patients?

Deft medication management is important.

Are RA Patients More Sensitive to Pain?

For many RA is complicated by fibromyalgia.

Meniscus Lesions Tied to Neuropathic Pain in Knee OA

Meniscal extrusion on MRI significantly associated with increasing pain scores in knee osteoarthritis.

Separating Spondyloarthritis From Back Pain Still Problematic

Spinal MRI criteria don't help differentiate SpA from nonspecific pain.

JIA Parents Lose Significant Work Time

More missed work in the year before and after a child's diagnosis of juvenile rheumatoid arthritis.

Painful Hands, Hurting Hearts?

Symptomatic hand osteoarthritis was linked with coronary heart disease.

Women, Blacks at Greater Risk for Bunions

Subgroups most likely to develop hallux valgus confirmed in major study.

NSAID Effective for RA Symptoms, Celebrex Easier on Stomach

Patients on celecoxib experienced greater pain reduction after 6 weeks of treatment.

Otezla Benefit Durable in PsA

Benefits persist through 2 years with apremilast in psoriatic arthritis.

Infection Risk Seen as Minimal With Denosumab

No increased risk whether administered alone or with DMARDs.

Novel Marker May Spot RA Early

This marker may differentiate between RA and OA.

Shingles Risks Similar for the RA Biologics

The risk of developing herpes zoster was similar among older patients with rheumatoid arthritis (RA) treated with the various different biologic agents, a retrospective study found.

鈥�

7